Skip to main content
OpenTrials
Completed

NCT Number: NCT02738164

SEPSIS 3 Critera for Risk Stratification in Emergency Patients

Investigators aim to evaluate the SEPSIS 3 criterion for "sepsis" and "septic shock" in a prospective manner.

Investigators will evaluate qSOFA performances and other SEPSIS 3 criterion in a population of emergency patients with infection

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

St Luc, Brussels, Belgium

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult that present to the emergency department
  • Diagnosis of infection by the treating emergency physician

Exclusion criteria

  • Refuse to participate
  • pregnancy
  • prisoner
  • Low acuity infection (localised, not requiring general treatment, without any abnormal vital parameters)

Treatment and study plan

Primary outcomes

  1. In hospital mortality

    Time frame: 30 days

Secondary outcomes

  1. admission in ICU

    Time frame: 30 days

  2. length of ICU stay more than 72 hours

    Time frame: 30 days

  3. Length of hospital stay

    Time frame: 30 days

Sponsors and collaborators

Lead sponsor

Societe Française de Medecine d'urgence

Other

Registry information

Official study title

Validation of the SEPSIS-3 Criterion for Sepsis and Septic Shock in the Emergency Department

Acronym: SCREEN

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Apr 14, 2016
Registry last updated
Jul 19, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.